---
document_datetime: 2023-09-21 17:46:33
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/vistide-epar-all-authorised-presentations_en.pdf
document_name: vistide-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6836521
conversion_datetime: 2025-12-22 16:32:12.33246
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented Name   | Strength   | Pharmaceutical Form                   | Route of administration   | Packaging    | Content (concentration)   | Package size   |
|-----------------|-----------------|------------|---------------------------------------|---------------------------|--------------|---------------------------|----------------|
| EU/1/97/037/001 | Vistide         | 75 mg/ml   | Concentrate for solution for infusion | Intravenous use           | Vial (glass) | 5 ml                      | 1 vial         |

<!-- image -->